UBS Group
COV

UBS Group’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

UBS Group’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,600
Closed -$368K – 10171
2014
Q4 		$368K Buy
+3,600
New +$345K ﹤0.01% 4474

UBS Group's COV Position: Q1 2015 in Review

UBS Group sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 1,617,105 shares — an estimated $165M sold.

UBS Group first reported a position in COV in Q4 2014 and held it in 1 quarter. The position peaked at $165M in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • UBS Group reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • UBS Group sold 1,617,105 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $165M.
  • UBS Group first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014 and held it in 1 quarter.
  • UBS Group's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $165M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on UBS Group's 13F filing for Q1 2015, filed 14 May 2015.